Effects of Psilocybin in Concussion Headache
Conditions
Diseases of the Nervous System | Mental Health & Behavioral Research | Pain Control
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to investigate the effects of oral psilocybin in post-traumatic headache. Subjects will be randomized to receive placebo, low dose psilocybin, or high dose psilocybin on two separate test days approximately 14 days apart. Subjects will maintain a headache diary prior to, during, and after the treatments in order to document headache frequency and intensity, as well as associated symptoms. Blood samples will be drawn at various timepoints to measure levels of inflammatory peptides.
- Ages21 years - 65 years
- GenderBoth
- Trial withCH TAC, LLC
- Start Date10/27/2016
- End Date06/30/2022
For more information about this study, contact:
Emmanuelle Schindler, MD, PhD
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigator
- Last Updated04/05/2022
- Study HIC#1607018057